BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9740692)

  • 1. Thrombocytosis as a prognostic factor in endometrial carcinoma.
    Gücer F; Moser F; Tamussino K; Reich O; Haas J; Arikan G; Petru E; Winter R
    Gynecol Oncol; 1998 Aug; 70(2):210-4. PubMed ID: 9740692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.
    Scholz HS; Petru E; Gücer F; Haas J; Tamussino K; Winter R
    Anticancer Res; 2000; 20(5C):3983-5. PubMed ID: 11268488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preoperative platelet count as index of the grading in endometrial carcinoma].
    Giannella L; Menozzi G; Di Monte I; Venturini P; De Pace V; Boselli F; Ternelli G; Jasonni VM
    Minerva Ginecol; 2008 Aug; 60(4):273-9. PubMed ID: 18560341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
    Rodriguez GC; Clarke-Pearson DL; Soper JT; Berchuck A; Synan I; Dodge RK
    Obstet Gynecol; 1994 Mar; 83(3):445-8. PubMed ID: 8127540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
    Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma.
    Lu CC; Chang KW; Chou FC; Cheng CY; Liu CJ
    Oral Oncol; 2007 Mar; 43(3):283-8. PubMed ID: 16920387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma.
    Ayhan A; Bozdag G; Taskiran C; Gultekin M; Yuce K; Kucukali T
    Gynecol Oncol; 2006 Dec; 103(3):902-5. PubMed ID: 16828847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
    Heng S; Benjapibal M
    Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of thrombocytosis in renal cell carcinoma.
    Bensalah K; Leray E; Fergelot P; Rioux-Leclercq N; Tostain J; Guillé F; Patard JJ
    J Urol; 2006 Mar; 175(3 Pt 1):859-63. PubMed ID: 16469566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
    Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
    Suppiah R; Shaheen PE; Elson P; Misbah SA; Wood L; Motzer RJ; Negrier S; Andresen SW; Bukowski RM
    Cancer; 2006 Oct; 107(8):1793-800. PubMed ID: 16983701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytosis in women with vulvar carcinoma.
    Lavie O; Comerci G; Daras V; Bolger BS; Lopes A; Monaghan JM
    Gynecol Oncol; 1999 Jan; 72(1):82-6. PubMed ID: 9889035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of thrombocytosis in resectable non-small cell lung cancer.
    Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):613-5. PubMed ID: 18502783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.